Manhattan Scients Stock Net Income
| MHTX Stock | USD 0.0001 0.00 0.00% |
In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Manhattan Scients, as well as the relationship between them.
Manhattan Scients' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Manhattan Scients' valuation are provided below:Manhattan Scients does not presently have any fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Manhattan |
Manhattan Scients 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Manhattan Scients' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Manhattan Scients.
| 11/05/2025 |
| 02/03/2026 |
If you would invest 0.00 in Manhattan Scients on November 5, 2025 and sell it all today you would earn a total of 0.00 from holding Manhattan Scients or generate 0.0% return on investment in Manhattan Scients over 90 days. Manhattan Scientifics, Inc., a technology incubator, engages in the development and commercialization of life-enhancing ... More
Manhattan Scients Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Manhattan Scients' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Manhattan Scients upside and downside potential and time the market with a certain degree of confidence.
Manhattan Scients Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Manhattan Scients' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Manhattan Scients' standard deviation. In reality, there are many statistical measures that can use Manhattan Scients historical prices to predict the future Manhattan Scients' volatility.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Manhattan Scients' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Manhattan Scients Backtested Returns
We have found three technical indicators for Manhattan Scients, which you can use to evaluate the volatility of the firm. The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Manhattan Scients are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Manhattan Scients has perfect predictability. Overlapping area represents the amount of predictability between Manhattan Scients time series from 5th of November 2025 to 20th of December 2025 and 20th of December 2025 to 3rd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Manhattan Scients price movement. The serial correlation of 1.0 indicates that 100.0% of current Manhattan Scients price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Manhattan Scients reported net income of (3.64 Million). This is 101.07% lower than that of the Biotechnology sector and 101.53% lower than that of the Health Care industry. The net income for all United States stocks is 100.64% higher than that of the company.
Manhattan Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Manhattan Scients' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Manhattan Scients could also be used in its relative valuation, which is a method of valuing Manhattan Scients by comparing valuation metrics of similar companies.Manhattan Scients is currently under evaluation in net income category among its peers.
Manhattan Fundamentals
| Return On Equity | -2.51 | |||
| Return On Asset | -0.17 | |||
| Operating Margin | (13.38) % | |||
| Current Valuation | 4.33 M | |||
| Shares Outstanding | 559.28 M | |||
| Shares Owned By Insiders | 18.63 % | |||
| Shares Owned By Institutions | 0.30 % | |||
| Price To Earning | 1.35 X | |||
| Price To Book | 15.64 X | |||
| Price To Sales | 99.55 X | |||
| Revenue | 50 K | |||
| Gross Profit | 50 K | |||
| EBITDA | (3.61 M) | |||
| Net Income | (3.64 M) | |||
| Cash And Equivalents | 386 K | |||
| Total Debt | 143 K | |||
| Debt To Equity | 0.09 % | |||
| Current Ratio | 0.26 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (421 K) | |||
| Earnings Per Share | (0.01) X | |||
| Target Price | 0.25 | |||
| Beta | 1.74 | |||
| Market Capitalization | 4.5 M | |||
| Total Asset | 3.45 M | |||
| Retained Earnings | (74.66 M) | |||
| Working Capital | 4.08 M | |||
| Current Asset | 5.36 M | |||
| Current Liabilities | 1.29 M | |||
| Z Score | -12.9 | |||
| Net Asset | 3.45 M |
About Manhattan Scients Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Manhattan Scients's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Manhattan Scients using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Manhattan Scients based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Manhattan Pink Sheet Analysis
When running Manhattan Scients' price analysis, check to measure Manhattan Scients' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Manhattan Scients is operating at the current time. Most of Manhattan Scients' value examination focuses on studying past and present price action to predict the probability of Manhattan Scients' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Manhattan Scients' price. Additionally, you may evaluate how the addition of Manhattan Scients to your portfolios can decrease your overall portfolio volatility.